Non-Current Assets
Other Non-Current Assets
Bristol-Myers Squibb Other Non-Current Assets increased by 6.7% to $6.33B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.8%, from $6.04B to $6.33B. Over 4 years (FY 2020 to FY 2024), Other Non-Current Assets shows a downward trend with a -3.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
Large fluctuations may relate to changes in long-term investment strategy or tax accounting adjustments.
Detailed definition
A catch-all category for long-term assets that do not fit into major classifications like PPE or Intangibles. This may i...
Peer comparison
Often contains strategic minority investments in technology partners or long-term tax-related items.
Metric ID:
other_non_current_assetsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $517.00M | $467.00M | $5.54B | $228.00M | $310.00M | $397.00M | $4.94B | $230.00M | $269.00M | $288.00M | $5.37B | $6.02B | $6.07B | $6.04B | $6.11B | $5.87B | $5.94B | $6.33B |
| QoQ Change | — | -9.7% | >999% | -95.9% | +36.0% | +28.1% | >999% | -95.3% | +17.0% | +7.1% | >999% | +12.2% | +0.8% | -0.4% | +1.0% | -3.9% | +1.2% | +6.7% |
| YoY Change | — | — | — | — | -40.0% | -15.0% | -10.7% | +0.9% | -13.2% | -27.5% | +8.7% | >999% | >999% | >999% | +13.7% | -2.6% | -2.2% | +4.8% |
Range$228.00M – $6.33B
CAGR+80.3%
Avg YoY Growth+470.8%
Median YoY Growth-0.7%
Current Streak2 quarters growth
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's other non-current assets?
- Bristol-Myers Squibb (BMY) reported other non-current assets of $6.33B in Q3 2025.
- How has Bristol-Myers Squibb's other non-current assets changed year-over-year?
- Bristol-Myers Squibb's other non-current assets increased by 4.8% year-over-year, from $6.04B to $6.33B.
- What is the long-term trend for Bristol-Myers Squibb's other non-current assets?
- Over 4 years (2020 to 2024), Bristol-Myers Squibb's other non-current assets has grown at a -3.4% compound annual growth rate (CAGR), from $7.02B to $6.11B.
- What does other non-current assets mean?
- Miscellaneous long-term investments and assets that the company plans to hold for more than a year.